Skip to main content
. 2018 Dec 6;44(12):317–323. doi: 10.14745/ccdr.v44i12a02

Table 1. Demographics, characteristics and outcomes among serotype 4 and non-serotype 4 cases of invasive pneumococcal disease within the South Island Health Service Delivery Area of Island Health (British Columbia, Canada), August 1, 2016–September 1, 2017.

Variable Serotype 4 Non-Serotype 4 p-value
n % n %
Total cases 33 100 51 100 N/A
Gender
   Male 23 69.70 29 56.86 0.34
Housing status
   Homeless or unstable housing 16 48.48 8 15.69 <0.01
Substance use
   Heavy alcohol use 13 39.39 16 31.37 0.80
   Injection drug use 10 30.30 5 9.80 0.054
   Cocaine 8 24.24 5 9.80 0.20
   Methamphetamine 10 30.30 3 5.88 <0.05
   Cannabis 18 54.55 8 15.69 <0.01
   Opioids 18 54.55 7 13.73 <0.001
   Tobacco smoking 27 81.82 18 35.29 <0.001
Co-morbidities
   HCV 7 21.21 9 17.65 1.00
   HIV 1 3.03 3 5.88 0.64
   Lung disease 9 27.27 23 45.10 0.086
   Cardiovascular disease 5 15.15 21 41.18 <0.05
   Renal disease 1 3.03 13 25.49 <0.01
   Diabetes 1 3.03 9 17.65 <0.05
IPD presentation
   Pneumonia 28 84.85 43 84.31 1.00
   Meningitis 2 6.06 3 5.88 1.00
Level of care
   Hospital admission 31 93.94 46 90.20 1.00
   ICU admission 10 30.30 12 23.53 0.70
Outcome
   In-hospital death 0 0 10 19.61 <0.01
Immunization
   Previous pneumococcal vaccinationa 3 9.09 8 15.69 0.52

Abbreviations: HCV, hepatitis C virus; ICU, intensive care unit; N/A, not applicable; n, number; <, inferior to

a Pneumococcal vaccination status was determined using electronic record systems that are known to be incomplete; reported numbers should be interpreted with caution

Note: Numbers rounded to the nearest decimal